• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

杀滴虫剂6-硝基-1-苯并咪唑衍生物化合物对……中代谢基因表达水平的影响

Effect of Trichomonacide 6-Nitro-1-benzimidazole Derivative Compounds on Expression Level of Metabolic Genes in .

作者信息

Gutiérrez-Cardona Jocelyn Yamin, Calderón-Jaimes Ernesto, Ortega-Cuellar Daniel, Sánchez-Carrillo Adrián, Castillo-Rodríguez Rosa Angélica, Canseco-Ávila Luis Miguel, Rocha-Ramírez Luz María, Martínez-Rosas Víctor, Gómez-Manzo Saúl, Hernández-Ochoa Beatriz

机构信息

Laboratorio de Inmunoquímica, Hospital Infantil de México Federico Gómez, Secretaría de Salud, Mexico City 06720, Mexico.

Laboratorio de Nutrición Experimental, Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City 04530, Mexico.

出版信息

Int J Mol Sci. 2024 Apr 22;25(8):4568. doi: 10.3390/ijms25084568.

DOI:10.3390/ijms25084568
PMID:38674152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11050703/
Abstract

The parasite is the etiologic agent of trichomoniasis, the most common non-viral sexually transmitted disease worldwide. This infection often remains asymptomatic and is related to several health complications. The traditional treatment for trichomoniasis is the use of drugs of the 5-nitroimidazole family, such as metronidazole; however, scientific reports indicate an increasing number of drug-resistant strains. Benzimidazole derivatives could offer an alternative in the search for new anti-trichomonas drugs. In this sense, two attractive candidates are the compounds and (1-benzimidazole derivatives), since, through in vitro tests, they have shown a higher trichomonacide activity. In this study, we determined the effect on the expression level of metabolic genes in . The results show that genes involved in redox balance (, ) are overexpressed, as well as the gene that participates in the first reaction of glycolysis (); on the other hand, structural genes such as and are decreased in expression in trophozoites treated with the compound , which would probably affect its morphology, motility and virulence. These results align with the trichomonacidal activity of the compounds, with benzimidazole being the most potent, with an IC value of 4.8 μM. These results are promising for potential future therapeutic applications.

摘要

这种寄生虫是滴虫病的病原体,滴虫病是全球最常见的非病毒性性传播疾病。这种感染通常没有症状,并与多种健康并发症相关。滴虫病的传统治疗方法是使用5-硝基咪唑类药物,如甲硝唑;然而,科学报告显示耐药菌株的数量在增加。苯并咪唑衍生物可能为寻找新的抗滴虫药物提供一种替代方案。从这个意义上说,两种有吸引力的候选化合物是化合物 和 (1-苯并咪唑衍生物),因为通过体外试验,它们显示出更高的杀滴虫活性。在这项研究中,我们确定了 对代谢基因表达水平的影响。结果表明,参与氧化还原平衡的基因( 、 )以及参与糖酵解第一步反应的基因( )过度表达;另一方面,在用化合物 处理的滋养体中,诸如 和 等结构基因的表达降低,这可能会影响其形态、运动性和毒力。这些结果与化合物的杀滴虫活性一致,其中苯并咪唑 最有效,IC值为4.8 μM。这些结果对未来潜在的治疗应用很有前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/11050703/02cbb3de00f0/ijms-25-04568-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/11050703/99b09a2f4da2/ijms-25-04568-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/11050703/00d0e93e823f/ijms-25-04568-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/11050703/4cdcdf3c5a54/ijms-25-04568-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/11050703/02cbb3de00f0/ijms-25-04568-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/11050703/99b09a2f4da2/ijms-25-04568-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/11050703/00d0e93e823f/ijms-25-04568-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/11050703/4cdcdf3c5a54/ijms-25-04568-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/11050703/02cbb3de00f0/ijms-25-04568-g008.jpg

相似文献

1
Effect of Trichomonacide 6-Nitro-1-benzimidazole Derivative Compounds on Expression Level of Metabolic Genes in .杀滴虫剂6-硝基-1-苯并咪唑衍生物化合物对……中代谢基因表达水平的影响
Int J Mol Sci. 2024 Apr 22;25(8):4568. doi: 10.3390/ijms25084568.
2
Pyridyl Methylsulfinyl Benzimidazole Derivatives as Promising Agents against and .嘧啶甲基亚磺酰基苯并咪唑衍生物作为有前途的 和 抑制剂。
Molecules. 2022 Dec 14;27(24):8902. doi: 10.3390/molecules27248902.
3
Imidazole Carbamates as a Promising Alternative for Treating Trichomoniasis: In Vitro Effects on the Growth and Gene Expression of .咪唑卡巴酯类化合物作为治疗滴虫病的一种有前途的替代方法:对 的生长和基因表达的体外影响。
Molecules. 2024 May 31;29(11):2585. doi: 10.3390/molecules29112585.
4
20S Proteasome as a Drug Target in Trichomonas vaginalis.20S 蛋白酶体作为阴道毛滴虫的药物靶点。
Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.00448-19. Print 2019 Nov.
5
The antimicrobial peptides LL-37, KR-20, FK-13 and KR-12 inhibit the growth of a sensitive and a metronidazole-resistant strain of Trichomonas vaginalis.抗菌肽 LL-37、KR-20、FK-13 和 KR-12 抑制敏感和甲硝唑耐药阴道毛滴虫株的生长。
Parasitol Res. 2022 Dec;121(12):3503-3512. doi: 10.1007/s00436-022-07674-6. Epub 2022 Sep 29.
6
[In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole].阴道毛滴虫对甲硝唑、奥硝唑以及质子泵抑制剂泮托拉唑和埃索美拉唑的体外敏感性
Mikrobiyol Bul. 2016 Jan;50(1):133-9.
7
Antiparasitic activity of furanyl N-acylhydrazone derivatives against Trichomonas vaginalis: in vitro and in silico analyses.呋喃基 N-酰腙衍生物抗阴道毛滴虫的驱虫活性:体外和计算分析。
Parasit Vectors. 2020 Feb 11;13(1):59. doi: 10.1186/s13071-020-3923-8.
8
Exploring novel pyrazole-nitroimidazole hybrids: Synthesis and antiprotozoal activity against the human pathogen trichomonas vaginalis.探索新型吡唑-硝基咪唑杂合体:合成及抗阴道毛滴虫人病原体的抗原生动物活性。
Bioorg Med Chem. 2024 Mar 15;102:117679. doi: 10.1016/j.bmc.2024.117679. Epub 2024 Mar 7.
9
Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.熊果酸衍生物对阴道毛滴虫的活性:一种有前景的替代方法。
Parasitol Res. 2018 May;117(5):1573-1580. doi: 10.1007/s00436-018-5839-1. Epub 2018 Mar 23.
10
Anti-Trichomonas vaginalis activity from triterpenoid derivatives.抗阴道毛滴虫三萜衍生物的活性。
Parasitol Res. 2014 Aug;113(8):2933-40. doi: 10.1007/s00436-014-3955-0. Epub 2014 Jun 1.

引用本文的文献

1
Imidazole Carbamates as a Promising Alternative for Treating Trichomoniasis: In Vitro Effects on the Growth and Gene Expression of .咪唑卡巴酯类化合物作为治疗滴虫病的一种有前途的替代方法:对 的生长和基因表达的体外影响。
Molecules. 2024 May 31;29(11):2585. doi: 10.3390/molecules29112585.

本文引用的文献

1
Recent achievements in the synthesis of benzimidazole derivatives.苯并咪唑衍生物合成的近期成果。
RSC Adv. 2023 Nov 7;13(46):32734-32771. doi: 10.1039/d3ra05960j. eCollection 2023 Oct 31.
2
An Atypical F-Actin Capping Protein Modulates Cytoskeleton Behaviors Crucial for Trichomonas vaginalis Colonization.一种非典型的 F-肌动蛋白封端蛋白调节阴道毛滴虫定植所必需的细胞骨架行为。
Microbiol Spectr. 2023 Aug 17;11(4):e0059623. doi: 10.1128/spectrum.00596-23. Epub 2023 Jun 13.
3
Iron restriction increases the expression of a cytotoxic cysteine proteinase TvCP2 by a novel mechanism of tvcp2 mRNA alternative polyadenylation in Trichomonas vaginalis.
铁限制通过一种新的 TvCP2 mRNA 可变多聚腺苷酸化机制增加阴道毛滴虫中细胞毒性半胱氨酸蛋白酶 TvCP2 的表达。
Biochim Biophys Acta Gene Regul Mech. 2023 Jun;1866(2):194935. doi: 10.1016/j.bbagrm.2023.194935. Epub 2023 Apr 2.
4
Pyridyl Methylsulfinyl Benzimidazole Derivatives as Promising Agents against and .嘧啶甲基亚磺酰基苯并咪唑衍生物作为有前途的 和 抑制剂。
Molecules. 2022 Dec 14;27(24):8902. doi: 10.3390/molecules27248902.
5
Metronidazole-resistant trichomoniasis: Two Canadian cases.甲硝唑耐药性滴虫病:两例加拿大病例。
J Assoc Med Microbiol Infect Dis Can. 2021 May 3;6(1):63-68. doi: 10.3138/jammi-2020-0044. eCollection 2021 Mar.
6
Omics Analyses of Actin and Tubulin and Their Participation in Intercellular Interactions and Cytokinesis.肌动蛋白和微管的组学分析及其在细胞间相互作用和胞质分裂中的参与。
Genes (Basel). 2022 Jun 15;13(6):1067. doi: 10.3390/genes13061067.
7
Sexually Transmitted Infections Treatment Guidelines, 2021.《2021年性传播感染治疗指南》
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.
8
Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study.单剂量口服塞克硝唑治疗女性滴虫病的疗效和安全性:3 期、随机、双盲、安慰剂对照、延迟治疗研究结果。
Clin Infect Dis. 2021 Sep 15;73(6):e1282-e1289. doi: 10.1093/cid/ciab242.
9
U.S. FDA Approved Drugs from 2015-June 2020: A Perspective.2015 年至 2020 年 6 月美国食品和药物管理局批准的药物:一个视角。
J Med Chem. 2021 Mar 11;64(5):2339-2381. doi: 10.1021/acs.jmedchem.0c01786. Epub 2021 Feb 22.
10
Developing a new drug against trichomoniasis, new inhibitory compounds of the protein triosephosphate isomerase.开发一种抗滴虫病的新药,磷酸丙糖异构酶蛋白的新型抑制化合物。
Parasitol Int. 2020 Jun;76:102086. doi: 10.1016/j.parint.2020.102086. Epub 2020 Feb 27.